Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution OCT

The OCT used in this trial offers the advantage of both a non-contact method and a very high axial resolution. Determined parameters with the highest potential of diagnostic discrimination between eyes with Keratoconus and healthy eyes are investigated. Aim of this trial is to investigate differences of specific parameters of epithelium thickness maps at healthy eyes and eyes with Keratoconus.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Keratoconus Corneal Diseases Eye Diseases

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna, Department of Ophthalmology

Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age>18
Existence of Keratoconus
written informed consent obtained

Exclusion criteria

Earlier surgery such as PK, CXL, relaxing incisions
Systemic diseases

Treatment and study plan

OCT-scanning

Device

All participants will be scanned with a OCT-device

Primary outcomes

Corneal Epithelium Thickness

Time frame: One visit

Parameters collected from epithelium thickness data and maps

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution Optical Coherence Tomography (UHR-OCT) Based Corneal Epithelium Thickness Mapping

Important dates

Study start: 2014
Primary completion: 2017
First posted: Jun 12, 2017
Registry last updated: Jun 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed